SpectraCure AB (FRA:2OK) Valuation Rank


FRA:2OK SpectraCure AB FRA:2OK
23 GF Score
Price €0.00
! 1 Warning Sign
View Full Analysis

What is SpectraCure AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

SpectraCure AB Valuation Rank Related Terms

FRA:2OK
23GF Score
SpectraCure AB FRA:2OK
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SpectraCure AB Business Description

Other Exchanges SPEC:Sweden
Address Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
23GF Score

Get the complete analysis for FRA:2OK

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price